The BioNTech/Pfizer vaccine was approved for use in the EU on 21 December 2020, followed on 6 January 2021 by the Moderna vaccine. Other projects are already at an advanced stage. Germany has secured large quantities of both of the vaccines already approved and of promising vaccine candidates. Here is an overview of the current stages of development of the various vaccines:
On behalf of the member states, the European Commission entered into contracts with manufacturers. During a global pandemic, unilateral actions at national level hamper effective health protection. "We very deliberately chose to act jointly with our partners in the European Union," stressed federal government spokesperson Steffen Seibert.
The European Medicines Agency (EMA) offers a comprehensive overview of the of a whole series of COVID-19 vaccines. According to the World Health Organization (WHO), 63 vaccine candidates are currently being tested on volunteers within the scope of clinical studies around the world. The WHO also provides an .
Our detailed FAQs provide answers to important questions relating to vaccinations.